Beyond Medicine is a digital therapeutics company committed to improving access to evidence-based care for chronic conditions. Its flagship product, Clickless, is a preion digital therapeutic for temporomandibular disorders (TMD), delivering jaw exercises, cognitive behavioral therapy, relaxation techniques, and behavioral interventions. Its clinical efficacy in reducing pain and improving jaw function has been demonstrated through a multicenter randomized controlled trial. Clickless has received medical device authorization and Innovative Medical Device designation in South Korea. The company is now expanding domestic preions and pursuing U.S. FDA clearance and global commercialization.